Register
Login:
Share:
Email Facebook Twitter




Add Immupharma to quick picks

Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 49.75Bid: 48.50Ask: 51.00Change: 1.75 (+3.65%)Riser - Immupharma
Spread: 2.50Spread as %: 5.15%Open: 48.00High: 49.75Low: 48.00Yesterday’s Close: 48.00

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
49.75

Share Price SpacerBid
48.50

Share Price SpacerAsk
51.00

Share Price SpacerChange
3.65%1.75

Share Price SpacerVolume
27,250

Share Price SpacerOpen
48.00

Share Price SpacerHigh
49.75

Share Price SpacerLow
48.00

Share Price SpacerClose
48.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 88.62m £44.09m 5,000

52 Week High 66.00 52 Week High Date 3-NOV-2014
52 Week Low 41.50 52 Week Low Date 9-JUN-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
7 0 27,250 -11.007 -4.52 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

27-Feb-15
15:52:25
50.45
1,250
Buy* 
48.50
51.00
630.63
Trade Type:
Ordinary

27-Feb-15
13:21:46
49.00
5,000
Buy* 
48.50
49.00
2,450
Trade Type:
Ordinary

27-Feb-15
13:18:49
49.00
10,000
Buy* 
48.00
49.00
4,900
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
23-Jan-12Buy
Trade Notifier Information for Immupharma
Franco Di Muzio held the position of Non-Executive Director at Immupharma at the time of this trade.
 Franco Di Muzio
81GBX60,9500
View more Immupharma directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Today 19:33
seagul
imm
49.75
Strong Buy

strong finish to the week here, should be fireworks when news hits
Today 15:47
jollyspeculator
IMMense potential
49.75
Weak Buy

good w/e, Dibs and all
Today 13:17
boomorbust
RE: Chelsea
48.25
No Opinion

Thanks Chelsea. Presenting under Autoimmune/Inflammation so Lupuzor. It seems like a long time since IMM last attended let alone presented at a conference so perhaps this is the start of ramping things up for Lupuzor. With phase III only lasting a year they will no doubt be looking to build awareness as much as possible.
Today 12:45
Dibs61
Chelsea
48.25
No Opinion

Thanks. Mixing with some big hitters there ;)
Today 12:36
CHELSEA7
PARIS 9=11th March 2015
48.25
No Opinion

http://www.ebdgroup.com/bes/presenters/prs_comps.php Seems you guys are booked to be showing here next................good luck!!!!
Today 12:25
Dibs61
RE: bought back @47.8p
48.00
No Opinion

Well done Jollers great entry price. This is one that I am happy to hold as core because my average is low - sub 50p - although I have traded a few previously. If and when they get major catalyst news I want to be in not trying to jump aboard as there isn't a big free float here.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Immupharma (IMM) >>
Please Login or Register to post messages






Sign up for Live Prices


CD02WL.001.081313


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.